Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.007 USD Market Closed
Market Cap: 22.8m USD
Have any thoughts about
Medivolve Inc?
Write Note

Intrinsic Value

The intrinsic value of one MEDVF stock under the Base Case scenario is 0.004 USD. Compared to the current market price of 0.007 USD, Medivolve Inc is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MEDVF Intrinsic Value
0.004 USD
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medivolve Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MEDVF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MEDVF?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Medivolve Inc

Provide an overview of the primary business activities
of Medivolve Inc.

What unique competitive advantages
does Medivolve Inc hold over its rivals?

What risks and challenges
does Medivolve Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medivolve Inc.

Provide P/S
for Medivolve Inc.

Provide P/E
for Medivolve Inc.

Provide P/OCF
for Medivolve Inc.

Provide P/FCFE
for Medivolve Inc.

Provide P/B
for Medivolve Inc.

Provide EV/S
for Medivolve Inc.

Provide EV/GP
for Medivolve Inc.

Provide EV/EBITDA
for Medivolve Inc.

Provide EV/EBIT
for Medivolve Inc.

Provide EV/OCF
for Medivolve Inc.

Provide EV/FCFF
for Medivolve Inc.

Provide EV/IC
for Medivolve Inc.

Compare the intrinsic valuations
of Medivolve Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medivolve Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medivolve Inc compared to its peers.

Compare the P/E ratios
of Medivolve Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Medivolve Inc with its peers.

Analyze the financial leverage
of Medivolve Inc compared to its main competitors.

Show all profitability ratios
for Medivolve Inc.

Provide ROE
for Medivolve Inc.

Provide ROA
for Medivolve Inc.

Provide ROIC
for Medivolve Inc.

Provide ROCE
for Medivolve Inc.

Provide Gross Margin
for Medivolve Inc.

Provide Operating Margin
for Medivolve Inc.

Provide Net Margin
for Medivolve Inc.

Provide FCF Margin
for Medivolve Inc.

Show all solvency ratios
for Medivolve Inc.

Provide D/E Ratio
for Medivolve Inc.

Provide D/A Ratio
for Medivolve Inc.

Provide Interest Coverage Ratio
for Medivolve Inc.

Provide Altman Z-Score Ratio
for Medivolve Inc.

Provide Quick Ratio
for Medivolve Inc.

Provide Current Ratio
for Medivolve Inc.

Provide Cash Ratio
for Medivolve Inc.

What is the historical Revenue growth
over the last 5 years for Medivolve Inc?

What is the historical Net Income growth
over the last 5 years for Medivolve Inc?

What is the current Free Cash Flow
of Medivolve Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medivolve Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medivolve Inc

Current Assets 904.3k
Cash & Short-Term Investments 400.6k
Receivables 295.9k
Other Current Assets 207.8k
Non-Current Assets 858.9k
PP&E 373.4k
Intangibles 485.5k
Current Liabilities 18.9m
Accounts Payable 9.2m
Accrued Liabilities 4.1m
Short-Term Debt 1.6m
Other Current Liabilities 3.9m
Non-Current Liabilities -281.2k
Other Non-Current Liabilities -281.2k
Efficiency

Earnings Waterfall
Medivolve Inc

Revenue
975.2k CAD
Cost of Revenue
-137.4k CAD
Gross Profit
837.8k CAD
Operating Expenses
-4.7m CAD
Operating Income
-3.8m CAD
Other Expenses
-13.8m CAD
Net Income
-17.6m CAD

Free Cash Flow Analysis
Medivolve Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MEDVF Profitability Score
Profitability Due Diligence

Medivolve Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROE
Exceptional ROIC
Positive Gross Profit
45/100
Profitability
Score

Medivolve Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

MEDVF Solvency Score
Solvency Due Diligence

Medivolve Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
30/100
Solvency
Score

Medivolve Inc's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDVF Price Targets Summary
Medivolve Inc

There are no price targets for MEDVF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MEDVF?

Click here to dive deeper.

Dividends

Medivolve Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MEDVF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Medivolve Inc Logo
Medivolve Inc

Country

Canada

Industry

Health Care

Market Cap

22.8m USD

Dividend Yield

0%

Description

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

Contact

ONTARIO
TORONTO
65 Queen St W Suite 800
+14168615888.0
medevolve.com

IPO

2009-11-16

Employees

-

Officers

Pres & CEO
Mr. David Preiner
VP of Legal & Member of Strategic Advisors
Mr. Neil Said
Chief Operating Officer - Collection Sites
Mr. Indivar Pathak
Corp. Sec.
Mr. Aaron Atin
Chief Financial Officer
Mr. Peter Michel
Mang. of Investor Relations
Dominique Vaillancourt

See Also

Discover More
What is the Intrinsic Value of one MEDVF stock?

The intrinsic value of one MEDVF stock under the Base Case scenario is 0.004 USD.

Is MEDVF stock undervalued or overvalued?

Compared to the current market price of 0.007 USD, Medivolve Inc is Overvalued by 45%.

Back to Top